Key Metrics
9.6
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
69
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.89
5-Year SI
5-year SI
- 0.88 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Hematology
SJR
- Q1 Hematology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.95
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
29%
4 to 6 months
50%
7 to 9 months
15%
Above 9 months
6%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
SJR
Topics Covered
- Overall survival
- Platelet
- Heparin
- Bone marrow
- Allele
- Hematopoietic stem cell transplantation
- Immunotherapy
- Anticoagulant
- Toxicity
- Progression-free survival
- Central nervous system
- Rituximab
- B-cell lymphoma
- Myeloid cells
- Mass spectrometry
- Antigen
- Hemoglobin
- Amyloidosis
- Germline
- Cell therapy
Journal Specifications
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Semi-monthly |
| General Details | |
| Language | English |
| Frequency | Semi-monthly |
| Publication Start Year | 2016 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Blood advances ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Sewastianik T, Jiang M, Sukhdeo K, etal. Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice. Blood Adv. 2017;1(25):2361-2374.
- 26 Nov 24
- Blood advances
-
Full paper
A contemporary downtrend in chronic GVHD?
- 26 Nov 24
- Blood advances
-
Full paper
Glisovic-Aplenc T, Diorio C, Chukinas JA, etal. CD38 as a pan-hematologic target for chimeric antigen receptor T cells. BloodAdv. 2023;7(16):4418-4430.
- 26 Nov 24
- Blood advances
-
Full paper
Cerebral vascular shunting and oxygen metabolism in sickle cell disease.
- 15 Nov 24
- Blood advances
-
Full paper
ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.
- 15 Nov 24
- Blood advances
-
Full paper
Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia.
- 15 Nov 24
- Blood advances
Scite analysis
Powered by scite_
4.7k articles received 88.6k citations see all
- 3,993 Supporting
- 82,653 Mentioning
- 530 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 10 Corrections
- 148 Errata
- 0 Expression of Concern
FAQs
How long has Blood advances been actively publishing?
Blood advances has been in operation since 2016 till date.
What is the publishing frequency of Blood advances ?
Blood advances published with a Semi-monthly frequency.
How many articles did Blood advances publish last years ?
In 2023, Blood advances published 891 articles.
What is the eISSN & pISSN for Blood advances ?
For Blood advances,eISSN is 2473-9537 and pISSN is2473-9529.
What is Citescore for Blood advances ?
Citescore for Blood advances is 9.6.
What is H index for Blood advances ?
H index for Blood advances is 69.
What is SNIP score for Blood advances ?
SNIP score for Blood advances is 1.95.
What is the SJR for Blood advances ?
SJR for Blood advances is Q1.
Who is the publisher of Blood advances ?
ELSEVIER is the publisher of Blood advances.